Related Research Articles
Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma. The laboratory analysis of blood is frequently performed by a medical technologist or medical laboratory scientist.
Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.
Minimal residual disease (MRD) is the name given to small numbers of leukaemic cells that remain in the person during treatment, or after treatment when the patient is in remission. It is the major cause of relapse in cancer and leukemia. Up until a decade ago, none of the tests used to assess or detect cancer were sensitive enough to detect MRD. Now, however, very sensitive molecular biology tests are available, based on DNA, RNA or proteins. These can measure minute levels of cancer cells in tissue samples, sometimes as low as one cancer cell in a million normal cells.
William S. Dalton is an American physician and oncologist, who is board certified in internal medicine and oncology. Since 2002 he has been the President, CEO, and Center Director of the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida (USF). He served as dean of the University of Arizona College of Medicine, 2001-2002.
Robert Peter Gale is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders.
Allen C. Eaves is the founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada. In 2016 he was awarded the Order of British Columbia as well as named Ernst and Young's Entrepreneur Of The Year™ Pacific.
Sir Peter Stanley Harper was a British physician and academic who was University Research Professor (Emeritus) in Human Genetics at Cardiff University. His work focused on researching neurogenetics and has resulted in discoveries concerning muscular dystrophies and Huntington's disease. He was knighted in 2004 for services to medicine.
Magne Børset is a Norwegian physician, Professor and Head of Department of Cancer Research and Molecular Medicine at Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. Børset is a senior consultant in clinical immunology and transfusion medicine. He is doing research on molecular oncology, immunology, and cancer cells from patients with multiple myeloma – a type of cancer which is localized to the bone marrow.
Kenneth Dawson Bagshawe, is a British oncologist, and Emeritus Professor of Medical Oncology, at Charing Cross Hospital.
Martin Bobrow is a British geneticist, and Emeritus Fellow, Wolfson College, Cambridge.
Sylvia Dorothy Lawler was an English geneticist who worked in the field of human genetics.
John M. Goldman was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. He was also a prolific author of scientific papers, was involved with numerous medical charities and had a decades-long surgical career at Hammersmith Hospital, London.
Steven Z. Pavletic is a Croatian-American physician and researcher in hematology and oncology known for his role in developing consensus guidelines for clinical trials in chronic Graft-versus-host disease (GVHD).
Lalit Kumar is an Indian oncologist, known to have contributed to the development of low cost medical facilities in Delhi. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine.
Ashok K. Vaid is an Indian medical oncologist, known for his pioneering efforts in bone marrow transplantation in India. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Surapol Issaragrisil is medical doctor and professor of medicine at Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University. He is an expert at hematology, bone marrow transplantation, and blood stem cells transplantation.
David Abraham Goitein Galton (1922-2006) was a British physician, specialising in haematology.
Professor Derek Crowther FRCP, FRCR is a British oncologist, and Professor Emeritus, School of Medical Sciences, University of Manchester.
Professor David Nichol Sharp Kerr (1927–2014) was a British nephrologist.
Professor Emeritus Sam H Ahmedzai FRCP, FRCPGlas, FFPMRCoA is a British supportive and palliative care specialist and an Honorary Consultant Physician in Palliative Medicine.
References
- 1 2 3 Daphne Christie; Tilli Tansey, eds. (2003). Leukaemia. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-85484-087-8. OL 21078818M. Wikidata Q29581665.
- 1 2 3 Britain, Pride of. "Prof. Ray Powles CBE and Prof. Trevor Powles CBE - Pride of Britain Awards". Pride of Britain . Retrieved 17 June 2017.
- ↑ "Professor Ray Powles". cancercentrelondon.co.uk. Cancer Centre London . Retrieved 17 June 2017.
